PCN107 COST COMPARISON OF ADVERSE EVENT MANAGEMENT WITH POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITORS (PARPI) IN THE MAINTENANCE TREATMENT OF ADVANCED OVARIAN CANCER
2020
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI